[The concept of the causal therapy of hirsutism].
Extended hormonal diagnosis allows causative treatment in hirsutism. By means of inhibition of the pituitary/gonadal axis and the androgenic metabolism at the cellular level, the androgenic action in hirsutism is extensively treated. Cyproterone acetate allows differentiated treatment according to the various grades of hirsutism by modification of dosage and application. Individual treatment according to the specific grade of hirsutism is also possible by different modes of application of medroxyprogesterone acetate. Intralesional application is a new interesting aspect of treatment. There have also been reported good results with spironalactone. Cimetidine may be another helpful alternative in cases of contraindicated hormonal treatment.
D002927:Cimetidine / Q000627:therapeutic use; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D006628:Hirsutism / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D011944:Receptors, Androgen / Q000187:drug effects; D013148:Spironolactone / Q000627:therapeutic use
D011944:Receptors, Androgen; D013148:Spironolactone; D017373:Cyproterone Acetate; D002927:Cimetidine; D017258:Medroxyprogesterone Acetate; D003534:Cyproterone; D008525:Medroxyprogesterone
Kausales Therapiekonzept beim Hirsutismus.